BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9706044)

  • 21. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
    Hunter J; Hirst BH; Simmons NL
    Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
    Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
    Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
    Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
    Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2).
    Hirohashi T; Suzuki H; Chu XY; Tamai I; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):265-70. PubMed ID: 10604957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
    Bourdet DL; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
    Hu M; Chen J
    Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa.
    Hsing S; Gatmaitan Z; Arias IM
    Gastroenterology; 1992 Mar; 102(3):879-85. PubMed ID: 1347031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X; Whitfield LR; Stewart BH
    Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza.
    Zhang J; Huang M; Guan S; Bi HC; Pan Y; Duan W; Chan SY; Chen X; Hong YH; Bian JS; Yang HY; Zhou S
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1285-94. PubMed ID: 16497784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
    Agarwal S; Jain R; Pal D; Mitra AK
    Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
    Liang E; Proudfoot J; Yazdanian M
    Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
    Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
    Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
    Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
    Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
    Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK
    J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The absorption and transport of magnolol in Caco-2 cell model.
    Wu AG; Zeng B; Huang MQ; Li SM; Chen JN; Lai XP
    Chin J Integr Med; 2013 Mar; 19(3):206-11. PubMed ID: 22903441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.